|
Current Issue November-December 2020
|
Vol 9 | Issue 6
 |
|
| Original Article |
| Does day 14 bone marrow status predict response to chemotherapy in acute myeloid leukemia? Experience of a hemato-oncology care center from Eastern India |
|
Background: Acute myeloid leukemia (AML), the most common type of acute leukemia in adults, yet continues to have the lowest survival rate of all leukemias. The present study aimed to study a... |
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
| Original Article |
| Heterogeneity: A stumbling block in the expression of human papillomaviruses 16 in oral squamous cell carcinoma |
 |
|
Background: Tobacco and smoking are the established risk factors for oral cancer, but studies have reported the occurrence of oral cancer, even in the absence of these established factors. Th... |
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| Original Article |
| Preoperative analysis of risk of malignancy indices in the distinction of malignant ovarian tumors |
 |
|
Background: Ovarian cancers are three times more lethal than breast cancer, despite its lower prevalence rate. Thus, it is imperative to determine if an ovarian mass is benign or malignant to... |
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
|
| Original Article |
| Sinonasal mucosal melanoma: A 9-year experience from a tertiary-cancer centre in South India |
 |
|
Sinonasal tract malignancies are uncommon, representing not more than 5% of all head and neck neoplasm. Primary sinonasal mucosal melanomas (SNMM) are rare and constitute 1% of all melanomas... |
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
| Original Article |
| Evaluation of Jak2 exon 12 mutation in patients with polycythemia vera |
 |
|
Background: Polycythemia vera (PV) increases the red blood cells' production. Jak2 Exon 12 mutation as a new molecular test can be helpful for diagnosing of PV patients. In this study, th... |
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
Abstracting and Indexing Information The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data The journal is indexed with, or included in, the following:
Emerging Sources Citation Index, Index Copernicus, Web of Science |
| |
|
|
Clinical Cancer Investigation Journal, a publication of Middle-Eastern Association for Cancer Research (MEACR),
is a peer-reviewed
online journal with
Quarterly print on
demand compilation of
issues published.
More
about the journal >>
|
|
Submit your manuscripts
- Online submission
- Wider visibility though
open access
- Higher impact with wider
visibility
- Prompt review
|
|
|
